Siemens acquires French MES vendor Elan

Siemens is expanding its industrial portfolio by acquiring Elan Software Systems SA, based in Toulouse, France, an international software supplier for manufacturing execution systems (MES) in the pharmaceutical and biotech industries. This step will enable Industry Automation, a division of the Siemens Industry Sector, to extend its global lead in the market for industrial software. Agreement was reached not to disclose the purchase price. In 2007 the division absorbed UGS in the USA and in 2008 Innotec in Germany, both companies being leading industrial software vendors in their particular fields.

With a workforce of 60, Elan Software Systems is a software and solutions supplier specializing in manufacturing execution systems in the pharmaceutical and biotech industries. This global player with its focus in France will be assigned to the Industrial Automation Systems Business Unit. "Particularly for the pharmaceutical and biotech industries, the Elan product range ideally supplements our Simatic IT MES portfolio, which is itself already a leader in its field. Elan has excellent manufacturing process know-how in these industries, where it has been a recognized partner and preferred software supplier to many well-known companies for twenty years. On this foundation we intend to build our worldwide MES software business in these industries", said Ralf-Michael Franke, Business Unit CEO.

According to Franke, Elan's business activities ideally complement the Siemens process industry portfolio, such as the Simatic IT MES portfolio, the process control system PCS 7 and the Comos life-cycle management systems added in 2008 by the acquisition of Innotec. "We will be continuing our successful strategy. Our customers can go on counting on our outstanding range of products and services and also rely on a strong partner under the Siemens roof who can offer them security of investment," commented Jean-Pierre Amadio, Managing Director of Elan Software Systems SA.

What are your comments?

Join the discussion today. Login Here.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments